Turnstone Biologics (TSBX) Institutional Ownership $0.41 +0.01 (+1.25%) As of 03/28/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Turnstone Biologics (NASDAQ:TSBX)CurrentInstitutional OwnershipPercentage52.51%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$951.54KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$289.46K Get TSBX Insider Trade Alerts Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TSBX Institutional Buying and Selling by Quarter Remove Ads Turnstone Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Millennium Management LLC73,744$37K0.0%-28.4%0.319% 2/12/2025 Takeda Pharmaceutical Co. Ltd.895,824$448K1.7%N/A3.873% 11/15/2024 Point72 Asset Management L.P.932,226$519K0.0%-16.7%4.030% 11/13/2024 FMR LLC1,172,987$653K0.0%+3.3%5.071% 8/19/2024 Point72 Asset Management L.P.1,118,588$2.93M0.0%-5.5%4.837% 8/13/2024 Sei Investments Co.11,882$31K0.0%N/A0.051% 5/17/2024 Zimmer Partners LP179,026$469K0.0%+271.4%0.774% 4/17/2024 Kathleen S. Wright Associates Inc.42,553$111K0.1%N/A0.184% 2/15/2024 PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742% 2/15/2024 Caas Capital Management LP45,831$117K0.0%-40.1%0.198% 12/6/2023 Citigroup Inc.7,524$30K0.0%N/A0.033% 11/15/2023 Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266% 11/14/2023 Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101% 11/13/2023 FMR LLC2,830,284$11.15M0.0%N/A12.392% 11/7/2023 New York State Common Retirement Fund18,867$74K0.0%N/A0.083% (Data available from 1/1/2016 forward)Remove Ads TSBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TSBX shares? During the previous two years, 13 institutional investors and hedge funds held shares of Turnstone Biologics. The most heavily invested institutionals were Eventide Asset Management LLC ($2.79M), Sectoral Asset Management Inc. ($2.04M), PFM Health Sciences LP ($1.61M), FMR LLC ($653K), Point72 Asset Management L.P. ($519K), Zimmer Partners LP ($469K), and Takeda Pharmaceutical Co. Ltd. ($448K).Learn more on TSBX's institutional investors. What percentage of Turnstone Biologics stock is owned by institutional investors? 52.51% of Turnstone Biologics stock is owned by institutional investors. Learn more on TSBX's institutional investor holdings. Which institutional investors have been buying Turnstone Biologics stock? Of the 9 institutional investors that purchased Turnstone Biologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.87M), Takeda Pharmaceutical Co. Ltd. ($895.82K), Eventide Asset Management LLC ($708.32K), Sectoral Asset Management Inc. ($517.65K), Zimmer Partners LP ($130.83K), Kathleen S. Wright Associates Inc. ($42.55K), and New York State Common Retirement Fund ($18.87K). How much institutional buying is happening at Turnstone Biologics? Institutional investors have bought a total of 5,201,463 shares in the last 24 months. This purchase volume represents approximately $17.04M in transactions. Which Turnstone Biologics major shareholders have been selling company stock? The following institutional investors have sold Turnstone Biologics stock in the last 24 months: PFM Health Sciences LP ($891.40K), Point72 Asset Management L.P. ($251.66K), Caas Capital Management LP ($30.68K), and Millennium Management LLC ($29.28K). How much institutional selling is happening at Turnstone Biologics? Institutional investors have sold a total of 1,203,020 shares in the last 24 months. This volume of shares sold represents approximately $2.64M in transactions. Related Companies FibroGen Institutional Ownership ALX Oncology Institutional Ownership Cadrenal Therapeutics Institutional Ownership OS Therapies Institutional Ownership Tempest Therapeutics Institutional Ownership Estrella Immunopharma Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Exicure Institutional Ownership NRx Pharmaceuticals Institutional Ownership LAVA Therapeutics Institutional Ownership This page (NASDAQ:TSBX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TSBX Stock Free TSBX Stock Alerts